Hikma Pharmaceutical | HIK - Assets

Stock Price
1,440.00
Daily Change
16.00 1.12%
Monthly
4.42%
Yearly
-30.37%
Q2 Forecast
1,414.37

Hikma Pharmaceutical reported $5.67B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Almirall EUR 2.34B 29.21M Dec/2025
argenx SE USD 8.68B 1.51B Dec/2025
AstraZeneca USD 114.02B 59M Mar/2026
Autolus Therapeutics Ltd USD 527.06M 62M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Fresenius EUR 41.4B 1.07B Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Orion EUR 2.08B 69.2M Mar/2026
Recordati EUR 5.25B 46.44M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
UCB EUR 18.16B 971M Dec/2025